Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The potential of epigenetic therapies in neurodegenerative diseases.
The Development of Prophylactic and Therapeutic EBV Vaccines.
The Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple Sclerosis.
Frequent laboratory abnormalities in CIDP patients.
Evaluation of Multi-Atlas Label Fusion for In Vivo MRI Orbital Segmentation.
Long-term follow-up of immunotherapy-unresponsive recurrent tumefactive demyelination.
Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis.
Multiple sclerosis for nurse practitioners.
Demyelinating disease: Novel markers for disease severity in neuromyelitis optica.
White and Gray Matter Volume Changes and Correlation with Visual Evoked Potential in Patients with Optic Neuritis: A Voxel-Based Morphometry Study.
PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions.
Polyreactive monoclonal autoantibodies in multiple sclerosis: functional selection from phage display library and characterization by deep sequencing analysis.
Vitamin d3 concentration correlates with the severity of multiple sclerosis.
Spanish consensus on the use of natalizumab (Tysabri(®))-2013.
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level-NO.
In Vivo Quantification of Inflammation in Experimental Autoimmune Encephalomyelitis Rats Using Fluorine-19 Magnetic Resonance Imaging Reveals Immune Cell Recruitment outside the Nervous System.
Comparing Three Dual-Task Methods and the Relationship to Physical and Cognitive Impairment in People with Multiple Sclerosis and Controls.
Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study.
Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders.
Vaccination, infection, and the risk for multiple sclerosis.
Ocular Toxicities of MEK inhibitors and other targeted therapies.
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.
Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research.
Response to: Tocilizumab, neuromyelitis optica (NMO), and multiple sclerosis.
Lipoprotein-associated lysolipids are differentially involved in high-density lipoprotein- and its oxidized form-induced neurite remodeling in PC12 cells.

Pages